Aligos Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Aligos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aligos Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aligos Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $292 | 298 | 0.98 |
| 2023-12-31 | $194 | 293 | 0.67 |
| 2023-09-30 | $145 | 195 | 0.75 |
| 2023-06-30 | $192 | 198 | 0.97 |
| 2022-12-31 | $165 | 173 | 0.95 |
| 2022-09-30 | $0 | 169 | 0.00 |
| 2022-06-30 | $0 | 125 | 0.00 |
| 2022-03-31 | $2.0k | 1.1k | 1.90 |
| 2021-12-31 | $101k | 8.6k | 11.83 |
| 2021-03-31 | $74k | 3.3k | 22.64 |
| 2020-12-31 | $145k | 5.2k | 27.63 |